i
2020 TB NAAT Utilization Survey Report
-
April 2022
[PDF-1.97 MB]
Details:
-
Alternative Title:Tuberculosis (TB) Nucleic Acid Amplification Test (NAAT) Utilization Survey
-
Corporate Authors:
-
Description:This report provides a summary of responses from the Association of Public Health Laboratories’ (APHL) 2020 Tuberculosis (TB) Nucleic Acid Amplification Test (NAAT) Utilization Survey. The TB NAAT Utilization Survey was fielded to public health laboratories and examined their capacities and capabilities to perform NAATs for the direct detection of Mycobacterium tuberculosis complex (MTBC). The survey also explored the ability of public health laboratories to perform and bill for TB NAAT on specimens received from outside their jurisdictions. The survey was fielded January 2020 through March 2020, with responses received from 89% (n=93 out of 104) of all invited participants. The goal of this survey and report is to provide comprehensive information regarding NAAT capacity and capability within public health laboratories and, subsequently, improve public health response and clinical outcome for TB patients and their potential contacts through efficient testing practices.
This project was 100% funded with federal funds from a federal program of $1,629,896. This publication was supported by Cooperative Agreement #NU60OE000104-02 from the US Centers for Disease Control and Prevention (CDC). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of CDC.
ID-2022-TB-NAAT-Survey-Report.pdf
-
Subjects:
-
Document Type:
-
Funding:
-
Pages in Document:10 numbered pages
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type:
